Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHF2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | SMAD2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | TTC30B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | CAMK1G | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | ZNF207 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | LPAR1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | PRSS51 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
mRNA | FAM210B | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |